scholarly journals The Future of Outcome Prediction for Preterm Infants in the Neonatal ICU

2021 ◽  
Author(s):  
Colm P Travers ◽  
Waldemar A Carlo ◽  
Namasivayam Ambalavanan
Keyword(s):  
Preterm Infants ◽  
Outcome Prediction ◽  
The Future ◽  
Neonatal Icu

scholarly journals Determinants of preterm infants’ deaths at the Neonatal Intensive Care Units in the Northeast Countryside in Brazil

2020 ◽  
Vol 20 (2) ◽  
pp. 535-544
Author(s):  
Raquel Gomes Lima ◽  
Verônica Cheles Vieira ◽  
Danielle Souto de Medeiros
Keyword(s):  
Mechanical Ventilation ◽  
Preterm Infants ◽  
Neonatal Intensive Care ◽  
Distress Syndrome ◽  
Neonatal Period ◽  
Invasive Mechanical Ventilation ◽  
Pulmonary Hemorrhage ◽  
Neonatal Intensive Care Units ◽  
Early Weaning ◽  
Neonatal Icu

Abstract Objectives: to assess preterm infants’ characteristics, health conditions and neonatal care effect on their death at the neonatal ICU. Methods: this was a non-concurrent cohort study, including preterm infants from three neonatal ICUs from January 1st to December 31st, 2016, followed during the neonatal period and deaths registered during the entire hospitalization. Multivariate analysis was performed using Poisson regression. Results: of the 181 preterm infants, 18.8% died during hospitalization. Associated with the outcome: a gestational age between 28 and 32 weeks (RR= 5.66; CI95%= 2.08-15.40), and less than 28 weeks (RR=9.24; CI95%=3.27-26.12), Apgar score of 5th minutes less than 7 (RR: 1.82; CI95%=1.08-3.08), use of invasive mechanical ventilation up to 3 days (RR= 4.44; CI95%= 1.66-11.87) and 4 days and more (RR=6.87; CI95%=2.58-18.27). Besides the late sepsis (RR: 3.72, CI95%=1.77-7.83), acute respiratory distress syndrome (RR=2.86, CI95%=1.49-5.46), pulmonary hemorrhage (RR=1.97; CI95%=1.40-2.77), and necrotizing enterocolitis (RR= 3.41; CI95%=1.70-6.83). Conclusions: the results suggest the importance of using strategies to improve care during childbirth, conditions for extremely premature infants, early weaning from a mechanical ventilation and prevention on nosocomial infection.

Trying to predict the future of ex-preterm infants: who benefits from a brain MRI at term?

2012 ◽  
Vol 101 (10) ◽  
pp. 1016-1017 ◽  
Author(s):  
Annie Janvier ◽  
Keith Barrington
Keyword(s):  
Preterm Infants ◽  
Brain Mri ◽  
The Future

The Future of Very Preterm Infants

JAMA ◽  
2008 ◽  
Vol 299 (12) ◽  
pp. 1477 ◽  
Author(s):  
Melissa M. Adams ◽  
Wanda D. Barfield
Keyword(s):  
Preterm Infants ◽  
Very Preterm Infants ◽  
Very Preterm ◽  
The Future

Using benchmarking to identify inter-centre differences in persistent ductus arteriosus treatment: can we improve outcome?

2017 ◽  
Vol 27 (8) ◽  
pp. 1488-1496 ◽  
Author(s):  
Esther J. S. Jansen ◽  
Koen P. Dijkman ◽  
Richard A. van Lingen ◽  
Willem B. de Vries ◽  
Daniel C. Vijlbrief ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Preterm Infants ◽  
Standard Procedure ◽  
Ductus Arteriosus ◽  
Short Term ◽  
Surgical Ligation ◽  
Persistent Ductus Arteriosus ◽  
Ductal Closure ◽  
Neonatal Icu ◽  
Patent Ductus

AbstractObjectiveThe aim of this study was to identify inter-centre differences in persistent ductus arteriosus treatment and their related outcomes.Materials and methodsWe carried out a retrospective, multicentre study including infants between 24+0 and 27+6 weeks of gestation in the period between 2010 and 2011. In all centres, echocardiography was used as the standard procedure to diagnose a patent ductus arteriosus and to document ductal closure.ResultsIn total, 367 preterm infants were included. All four participating neonatal ICU had a comparable number of preterm infants; however, differences were observed in the incidence of treatment (33–63%), choice and dosing of medication (ibuprofen or indomethacin), number of pharmacological courses (1–4), and the need for surgical ligation after failure of pharmacological treatment (8–52%). Despite the differences in treatment, we found no difference in short-term morbidity between the centres. Adjusted mortality showed independent risk contribution of gestational age, birth weight, ductal ligation, and perinatal centre.ConclusionsUsing benchmarking as a tool identified inter-centre differences. In these four perinatal centres, the factors that explained the differences in patent ductus arteriosus treatment are quite complex. Timing, choice of medication, and dosing are probably important determinants for successful patent ductus arteriosus closure.

Sign in / Sign up

Export Citation Format

Share Document